Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
1
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Background: Gonadotropin-releasing hormone (GnRH) stimulation test is the gold standard to identify central precocious puberty (CPP). This test requires multiple blood samples at different time points to measure gonadotropin levels, and is therefore expensive, time-consuming, and uncomfortable for patients. We aimed to simplify the GnRH stimulation test to require fewer blood samples. Methods: A study of 166 girls with precocious puberty was undertaken. Blood samples were obtained at 0, 15, 30, 45, 60, 90, and 120 min after GnRH administration, and the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were measured. For each parameter, the sensitivities and specificities were estimated and ROC curves were constructed. Results: One hundred and twenty-eight patients (77.1%) were diagnosed for CPP. Peak LH levels were achieved 30 min after GnRH stimulation in patients with CPP. Further, 98.4% of the 45-min samples were diagnostic for CPP, and the cumulative frequency of LH values of ≥5 IU/L was 100% at 45 min. Using this cut-off value for LH, the ROC curve for LH at 45 min showed the highest sensitivity (98.4%) and specificity (100%) in the diagnosis of CPP. Conclusions: Values of LH measured from a single blood sample obtained at 45 min in the GnRH stimulation test may be adequate for the diagnosis of CPP. Two samples, taken at 30 and 45 min after stimulation, were able to accurately diagnose CPP in 100% of the patients in this study.
Abstract
Background: Gonadotropin-releasing hormone (GnRH) stimulation test is the gold standard to identify central precocious puberty (CPP). This test requires multiple blood samples at different time points to measure gonadotropin levels, and is therefore expensive, time-consuming, and uncomfortable for patients. We aimed to simplify the GnRH stimulation test to require fewer blood samples. Methods: A study of 166 girls with precocious puberty was undertaken. Blood samples were obtained at 0, 15, 30, 45, 60, 90, and 120 min after GnRH administration, and the levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were measured. For each parameter, the sensitivities and specificities were estimated and ROC curves were constructed. Results: One hundred and twenty-eight patients (77.1%) were diagnosed for CPP. Peak LH levels were achieved 30 min after GnRH stimulation in patients with CPP. Further, 98.4% of the 45-min samples were diagnostic for CPP, and the cumulative frequency of LH values of ≥5 IU/L was 100% at 45 min. Using this cut-off value for LH, the ROC curve for LH at 45 min showed the highest sensitivity (98.4%) and specificity (100%) in the diagnosis of CPP. Conclusions: Values of LH measured from a single blood sample obtained at 45 min in the GnRH stimulation test may be adequate for the diagnosis of CPP. Two samples, taken at 30 and 45 min after stimulation, were able to accurately diagnose CPP in 100% of the patients in this study.
참고문헌 (26)
- Parent AS, "The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration", Endocr Rev, 24, pp.668~693 (2003)
- Carel JC, "Consensus statement on the use of gonadotropin-releasing hormone analogs in children", Pediatrics, 123, pp.752~762 (2009)
- Lee PA, "Central precocious puberty. An overview of diagnosis, treatment, and outcome", Endocrinol Metab Clin North Am, 28, pp.901~918 (1999)
- Partsch CJ, "Management and outcome of central precocious puberty", Clin Endocrinol (Oxf), 56, pp.129~148 (2002)
- Brito VN, "Diagnostic value of fluorometric assays in the evaluation of precocious puberty", J Clin Endocrinol Metab, 84, pp.3539~3544 (1999)
- Lee PA, "Laboratory monitoring of children with precocious puberty", Arch Pediatr Adolesc Med, 148, pp.369~376 (1994)
- Poomthavorn P, "Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty", Horm Res, 72, pp.114~119 (2009)
- Pescovitz OH, "Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone", J Clin Endocrinol Metab, 67, pp.474~479 (1988)
- Parker KL, "Depot leuprolide acetate dosage for sexual precocity", J Clin Endocrinol Metab, 73, pp.50~52 (1991)
- Cavallo A, "A simplified gonadotrophin-releasing hormone test for precocious puberty", Clin Endocrinol (Oxf), 42, pp.641~646 (1995)
- Toguchi H, "Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance", J Int Med Res, 18(1), pp.35~41 (1990)
- Manasco PK, "Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty", J Pediatr, 115, pp.105~108 (1989)
- Witchel SF, "Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy", J Clin Endocrinol Metab, 81, pp.1353~1356 (1996)
- Neely EK, "Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty", J Pediatr, 127, pp.47~52 (1995)
- Houk CP, "Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls", Pediatrics, 123, pp.1059~1063 (2009)
- Houk CP, "The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate", J Pediatr Endocrinol Metab, 21, pp.1113~1118 (2008)
- Ibáñez L, "Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test", J Clin Endocrinol Metab, 781, pp.30~35 (1994)
- Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist. 2nd ed" (1959), Stanford University Press
- Neely EK, "Normal ranges for immunochemiluminometric gonadotropin assays", J Pediatr, 127, pp.40~46 (1995)
- Mogensen SS, "Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty", J Clin Endocrinol Metab, 96, pp.1393~1401 (2011)
- Resende EA, "Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children", J Clin Endocrinol Metab, 92, pp.1424~1429 (2007)
- Oerter KE, "Gonadotropin secretory dynamics during puberty in normal girls and boys", J Clin Endocrinol Metab, 71, pp.1251~1258 (1990)
- Eckert KL, "A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty", Pediatrics, 97, pp.517~519 (1996)
- Cavallo A, "LHRH test in the assessment of puberty in normal children", Horm Res, 41, pp.10~15 (1994)
- Brito VN, "A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls", J Clin Endocrinol Metab, 89, pp.4338~4342 (2004)
- Choi JH, "The predictive factors for central nervous system lesion in central precocious puberty and the utility of single timed LH after GnRH administration", J Korean Soc Pediatr Endocrinol, 7, pp.206~214 (2002)